PO.CL01.12 · 临床研究
卵巢癌组织样本的三维空间多组学表征
3D spatial multiomics characterization of ovarian cancer tissue samples
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
卵巢癌中遗传改变、细胞环境与免疫应答之间复杂的相互作用,要求采用先进的分析方法来指导个性化治疗。传统的二维分析无法捕捉肿瘤复杂的三维(3D)结构和细胞组织,限制了对免疫动态与肿瘤微环境的洞察。为克服这一局限,我们开发了一套整合三维多组学的全自动空间生物学工作流程。该流程结合了用于精确RNA检测的RNAsky®技术,以及采用重组REAfinity™和REAdye_lease™抗体偶联物进行的多重蛋白分析,并通过MACS® iQ View - 空间生物学图像分析软件进行准确的三维分割。z维度上纳入多个层面,能够对单个细胞进行精确注释,从而在单细胞水平实现RNA和蛋白的精确定位。通过采用免疫肿瘤学抗体panel和互补的RNA panel分析卵巢癌组织,我们对原发、未经治疗的卵巢癌组织及其微环境进行了表征。这使得对多种淋巴细胞群体(包括T细胞、B细胞和NK细胞)以及髓系细胞(如树突状细胞和巨噬细胞)进行空间定位成为可能。此外,还对癌细胞进行了表征,并识别了涵盖成纤维细胞、内皮细胞和神经元细胞的基质区室。这些方面揭示了可能影响肿瘤进展和治疗应答的结构与免疫学特征。三维分析揭示了各种细胞类型之间的空间关系,尤其是,三维分析解析了组织结构的关键解剖学特征,而这些特征在肿瘤生长和转移中发挥着至关重要的作用。通过将这些三维空间数据与临床结局相关联,该工作流程可为耐药机制、潜在生物标志物和治疗靶点提供见解。这一整合式三维多组学工作流程提供了肿瘤组织结构与免疫背景的整体、高分辨率视图,推进了对卵巢癌生物学的理解,并支持跨癌种的精准医学。
查看英文原文 English abstract
The complex interplay between genetic alterations, cellular environments, and immune responses in ovarian cancer demands advanced analytical approaches to inform personalized therapies. Conventional two-dimensional analyses fail to capture the tumor's complex three-dimensional (3D) architecture and cellular organization, limiting insight into immune dynamics and the tumor microenvironment. To overcome this, we developed a fully automated spatial biology workflow integrating 3D multiomics. This workflow combines RNAsky® technology for precise RNA detection with multiplexed protein profiling using recombinant REAfinity™ and REAdye_lease™ antibody conjugates, analyzed via the MACS® iQ View - Spatial Biology Image Analysis Software for accurate 3D segmentation. The inclusion of multiple layers in the z-dimension allows precise annotation of individual cells, and thus precise RNA and protein localization at the single-cell level. By analyzing ovarian cancer tissues with an immuno-oncology antibody panel and a complementary RNA panel, we characterized primary, untreated ovarian cancer tissues and their microenvironment. This enabled spatial mapping of diverse lymphoid cell populations including T-cells, B-cells, and NK cells, as well as cells of myeloid lineage such as dendritic cells and macrophages. Additionally, cancer cells were characterized and the stromal compartment encompassing fibroblasts, endothelial and neuronal cells were identified. These aspects revealed structural and immunological features which may influence tumor progression and treatment response. The 3D analysis uncovered spatial relationships among various cell types, in particular, 3D analysis resolved key anatomical features of tissue architecture, which play crucial roles in tumor growth and metastasis. By correlating these 3D spatial data with clinical outcomes, the workflow may provide insights into resistance mechanisms, potential biomarkers, and therapeutic targets. This integrated 3D multiomics workflow offers a holistic, high-resolution view of tumor organization and immune contexture, advancing the understanding of ovarian cancer biology and supporting precision medicine across cancer types.
利益披露 Disclosure
L. Nolte,
Miltenyi Biotec Employment.
D. Bessa-Neto,
Miltenyi Biotec Employment.
S. Baghdo,
Miltenyi Biotec Employment.
B. Szabó,
Miltenyi Biotec Employment.
F. El Yassouri,
Miltenyi Biotec Employment.
E. Neil,
Miltenyi Biotec Employment.
R. Pinard,
Miltenyi Biotec Employment.
W. Müller,
Miltenyi Biotec Employment.
D. Eckardt,
Miltenyi Biotec Employment.
C. Herbel,
Miltenyi Biotec Employment.
A. Bosio,
Miltenyi Biotec Employment.